METHOD FOR DETERMINING DEGREE OF SEVERITY OF INFANTILE CEREBRAL PARALYSIS IN INFANTS Russian patent published in 2015 - IPC G01N33/48 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to a method for determining a degree of severity of infantile cerebral paralysis in infants. The method consists in measuring clinical signs of the disease; the infant's peripheral blood is analysed for erythrocytes with micronuclei; the clinical signs of the diseases are rated according to the Rivermead scale; an enzyme immunoassay is used to measure the tumour necrosis factor (TNF-α) in the infant's peripheral blood serum in the infants suffering from infantile cerebral paralysis, measured to the clinical signs; if the measured erythrocytes with micronuclei are found in the number of 0.55±0.14%, whereas serum TNF-α increases to 6.14±3.025 pg/ml, a moderate degree of severity is stated, while the measured count of erythrocytes with micronuclei is 1.27±0.47% and more with the serum TNF-α of 9.58±0.39 pg/ml and more shows a severe degree.

EFFECT: using the declared method enables developing the faster and less invasive method for determining the degree of severity of infantile cerebral paralysis.

5 dwg, 8 tbl, 2 ex